Abstract
The growing prevalence of obesity and its destructive effects on the hormone’s circulation and brain structures has attracted attention to specific dietary patterns. This trial aimed to examine the effect of short-term newly Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) pattern on anthropometric parameters, hunger hormones as well as brain structures in obese women. The study was a randomized restricted controlled trial in which we analyzed 37 healthy obese women with a mean age of 48 ± 5.38 years and mean Body Mass Index (BMI) 32 ± 4.31 kg/m2. Participants were randomly allocated to a hypocaloric modified MIND diet or a hypocaloric waiting list control diet and followed the protocols for three months. Differences in anthropometric and laboratory analysis, as well as brain structures, were determined at baseline and follow up. There was a more significant reduction in weight, BMI, percentage of body fat, waist circumference, and Leptin concentration in the MIND diet group compared to the control group (ps<0.05). Despite a deceased in plasma levels of Ghrelin and GLP-1 in the control group, results have found a significant increase in these hunger hormones in the MIND diet group (ps<0.05). Our results diminished to detect any differences in the whole and regional brain structures between two groups after three months follow up. Our trial for the first time demonstrated that a three-month MIND diet intervention could improve the potentially devastating effect of obesity on metabolic profiles and anthropometric parameters. However, we couldn’t find the MIND diet effect on brain structures.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04383704
Funding Statement
This trial was financially supported by Shiraz University of Medical Science, Shiraz, Iran (Grant numbers: 97-01-84-17299).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Participant's recruitment was performed after approval by the Ethics Committee of the Shiraz University of Medical Science, and participants provided signed informed consent before participation. The study was carried out in agreement with the principles of the Helsinki Declaration.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data referred to in the manuscript.
